You may be considering enrolling in the ongoing global atypical hemolytic uremic syndrome (aHUS) registry. Here are some frequently asked questions and answers about the registry to help you learn ... Read more
Soliris (eculizumab) is a medication developed by Alexion to treat atypical hemolytic uremic syndrome (aHUS). Here are some frequently asked question and answers about Soliris: How does Soliris work? ... Read more
Ultomiris (ravulizumab-cwvz) is a treatment for atypical hemolytic uremic syndrome (aHUS) that was developed by Alexion. The therapy is designed to treat people with low levels of circulating red blood ... Read more
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by the formation of blood clots in the small blood vessels of the kidneys. The kidneys filter waste out ... Read more
Atypical hemolytic uremic syndrome (aHUS) is a rare genetic disease associated with symptoms such as hemolytic anemia (loss of red blood cells) and thrombocytopenia (low platelet count). In severe ... Read more
Information about rare diseases such as atypical hemolytic uremic syndrome (aHUS) can be difficult to find, complicating the situation for both patients and caregivers. Here are answers to some ... Read more
